Main > PNEUMOLOGY > Asthma > Treatment > DaclizuMAb (IL-2 Inhibitor) > Co.: USA. A. (Phase II/Patents)
Co.: USA. A. (Phase II/Patents)'s subsections
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 03.13.07
UpDate: 03.2007
Co.: USA. A. (Phase II/Patents)'s products
This section has no products